Supplementary Table S6 from An Early Neoplasia Index (ENI10), Based on Molecular Identity of CD10 Cells and Associated Stemness Biomarkers, is a Predictor of Patient Outcome in Many Cancers

Boris Guyot; Flora Clément; Youenn Drouet; Xenia Schmidt; Sylvain Lefort; E. Delay; Isabelle Treilleux; Jean‐Philippe Foy; Sandrine Jeanpierre; Emilie Thomas; Janice Kielbassa; Laurie Tonon; Helen He Zhu; Pierre Saintigny; Wei‐Qiang Gao; Arnaud de la Fouchardière; Franck Tirode; Alain Viari; Jean Yves Blay; Véronique Maguer‐Satta

doi:10.1158/2767-9764.24220856

Shared by

Jean Yves Blay

Supplementary Table S6 from An Early Neoplasia Index (ENI10), Based on Molecular Identity of CD10 Cells and Associated Stemness Biomarkers, is a Predictor of Patient Outcome in Many Cancers

Dataset en

Authors

BG
Boris Guyot
FC
Flora Clément
YD
Youenn Drouet

Abstract

1 min read

<p>Supplementary Table S6 shows the correlation between the ENI10 score and the IC50 of the indicated drugs in cancer cell lines from the "Genomics of Drug Sensitivity in Cancer Project".</p>

Discussion(0)

No comments yet. Be the first to comment.

Supplementary Table S6 from An Early Neoplasia Index (ENI10), Based on Molecular Identity of CD10 Cells and Associated Stemness Biomarkers, is a Predictor of Patient Outcome in Many Cancers

Abstract

Discussion(0)

Related publications

Supplementary Table S6 from An Early Neoplasia Index (ENI10), Based on Molecular Identity of CD10 Cells and Associated Stemness Biomarkers, is a Predictor of Patient Outcome in Many Cancers

Supplementary Table S4 from An Early Neoplasia Index (ENI10), Based on Molecular Identity of CD10 Cells and Associated Stemness Biomarkers, is a Predictor of Patient Outcome in Many Cancers

Supplementary Table S4 from An Early Neoplasia Index (ENI10), Based on Molecular Identity of CD10 Cells and Associated Stemness Biomarkers, is a Predictor of Patient Outcome in Many Cancers

FIGURE 5 from An Early Neoplasia Index (ENI10), Based on Molecular Identity of CD10 Cells and Associated Stemness Biomarkers, is a Predictor of Patient Outcome in Many Cancers

FIGURE 5 from An Early Neoplasia Index (ENI10), Based on Molecular Identity of CD10 Cells and Associated Stemness Biomarkers, is a Predictor of Patient Outcome in Many Cancers

Related publications

Dataset
Supplementary Table S6 from An Early Neoplasia Index (ENI10), Based on Molecular Identity of CD10 Cells and Associated Stemness Biomarkers, is a Predictor of Patient Outcome in Many Cancers

Dataset
Supplementary Table S4 from An Early Neoplasia Index (ENI10), Based on Molecular Identity of CD10 Cells and Associated Stemness Biomarkers, is a Predictor of Patient Outcome in Many Cancers

Dataset
Supplementary Table S4 from An Early Neoplasia Index (ENI10), Based on Molecular Identity of CD10 Cells and Associated Stemness Biomarkers, is a Predictor of Patient Outcome in Many Cancers

Preprint2023
FIGURE 5 from An Early Neoplasia Index (ENI10), Based on Molecular Identity of CD10 Cells and Associated Stemness Biomarkers, is a Predictor of Patient Outcome in Many Cancers
Preprint2023

Preprint2023
FIGURE 5 from An Early Neoplasia Index (ENI10), Based on Molecular Identity of CD10 Cells and Associated Stemness Biomarkers, is a Predictor of Patient Outcome in Many Cancers
Preprint2023